The global Gastrointestinal Stromal Tumors (GIST) therapeutics market is witnessing significant growth due to the increasing prevalence of rare gastrointestinal cancers, advancements in targeted therapies, and rising awareness regarding early diagnosis and treatment. Pharmaceutical companies are investing heavily in research and development activities to introduce innovative therapies that...